A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients

Clinical trial NCT04550897 · TERMINATED

Trial details

NCT number: NCT04550897
Sponsor: Oslo University Hospital
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2020-08-31
Primary completion: 2024-06-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.